Sera Prognostics (SERA) Current Assets (2020 - 2026)
Sera Prognostics' (SERA) quarterly Current Assets came in at $49.7 million in Q1 2026, up 5.17% YoY from $47.3 million in Q1 2025, and up 21.97% on a QoQ basis from $40.8 million in Q4 2025.
Sera Prognostics (SERA) Current Assets (2020 - 2026) Analysis & Trends
Sera Prognostics (SERA) has 7 years of Current Assets data on file, last reported at $49.7 million in Q1 2026.
- Quarterly Current Assets rose 5.17% year-over-year to $49.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $49.7 million (up 5.17% YoY) and the FY2025 annual result came in at $40.8 million, down 14.35% from the prior year.
- Current Assets improved to $49.7 million in Q1 2026, from $40.8 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $109.5 million in Q1 2022 to a low of $40.8 million in Q4 2025.
- A 5-year average of $63.0 million and a median of $51.5 million in 2024 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2022 — Current Assets grew 18.26% — and 2023, when it plunged 47.66%.
- Tracing SERA's Current Assets over 5 years: stood at $90.1 million in 2022, then plunged by 31.93% to $61.3 million in 2023, then dropped by 22.4% to $47.6 million in 2024, then decreased by 14.35% to $40.8 million in 2025, then advanced by 21.97% to $49.7 million in 2026.
- The last three Current Assets figures came in at $49.7 million (Q1 2026), $40.8 million (Q4 2025), and $44.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 24.52 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 14.42 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 24.79 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 7.97 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 6.82 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 4.09 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 10.50 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 10.84 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 2.45 Bn |
| 10 | Sera Prognostics | 103.48 Mn | 103.48 Mn | -20,000.00 | 48.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 48.13 Mn |
| Mar 31, 2026 | 49.73 Mn |
| Dec 31, 2025 | 40.77 Mn |
| Sep 30, 2025 | 44.49 Mn |
| Jun 30, 2025 | 40.87 Mn |
| Mar 31, 2025 | 47.28 Mn |
| Dec 31, 2024 | 47.60 Mn |
| Sep 30, 2024 | 51.11 Mn |
| Jun 30, 2024 | 51.54 Mn |
| Mar 31, 2024 | 53.85 Mn |
| Dec 31, 2023 | 61.34 Mn |
| Sep 30, 2023 | 47.55 Mn |
| Jun 30, 2023 | 64.43 Mn |
| Mar 31, 2023 | 72.11 Mn |
| Dec 31, 2022 | 90.13 Mn |
| Sep 30, 2022 | 90.84 Mn |
| Jun 30, 2022 | 108.05 Mn |
| Mar 31, 2022 | 109.47 Mn |
| Dec 31, 2021 | 110.25 Mn |
| Sep 30, 2021 | 122.34 Mn |